80. 甲状腺ホルモン不応症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 1 / 薬物数 : 4 - (DrugBank : 3) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 4
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Hypothyroidism QOL questionnaire
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Thyrotropin releasing hormone
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
TRH
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Thyrotropin releasing hormone
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
TRH
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States